Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neurophotometrics is a scientist-run neuroscience tools company focused on fiber photometry instrumentation for academic and industrial research. The company developed plug-and-play optical systems for recording calcium and neurotransmitter indicator signals in freely moving animals across multiple brain regions, with products such as the FP3001 and second-generation FP3002. The FP3002 adds integrated optogenetic stimulation, dual-color imaging capability, and multi-region recording, positioning the company as a specialized provider of neurotechnology hardware rather than a therapeutic drug developer. In October 2023, Neurophotometrics was acquired by MBF Bioscience and now operates as part of the MBF Bioscience family, with the San Diego site identified as the Neurophotometrics division. Its business appears centered on commercial research instruments, accessories, software-enabled workflows, and collaboration with academic and industry neuroscience labs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neurophotometrics.